Advanced search
Publication Cover
Clinical Ophthalmology Volume 13, 2019 - Issue
Submit an article Journal homepage
167
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease

Elizabeth Yeu1 Eastern Virginia Medical School, Virginia Eye Consultants, Norfolk, VA, USA
,
Damien F Goldberg2 Wolstan & Goldberg Eye Associates, Torrance, CA, USACorrespondence[email protected]
,
Francis S Mah3 Scripps Clinic Torrey Pines, La Jolla, CA, USA
,
Kenneth A Beckman4 Ohio State University, Columbus, OH, USA;5 Comprehensive Eye Care of Central Ohio, Westerville, OH, USA
,
Jodi I Luchs6 Hofstra Northwell School of Medicine, Hempstead, NY, USA;7 South Shore Eye Care, Wantagh, NY, USA
,
Jonathan D Solomon8 Bowie Vision Institute, Bowie, MD, USA
,
Darrell E White9 Skyvision Centers, Westlake, OH, USA
&
Preeya K Gupta10 Duke University Eye Center, Durham, NC, USA
 show all
Pages 887-894 | Published online: 27 May 2019

References

  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
  • Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574. doi:10.1016/j.jtos.2017.05.001
  • Milner MS, Beckman KA, Luchs JI, et al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27(Suppl 1):3–47. doi:10.1097/01.icu.0000512373.81749.b7
  • Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–365. doi:10.1016/j.jtos.2017.05.003
  • Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575–628. doi:10.1016/j.jtos.2017.05.006
  • Malhotra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant. 2014;4(2):111–121. doi:10.5500/wjt.v4.i2.111
  • Cheng AM, Zhao D, Chen R, et al. Accelerated restoration of ocular surface health in dry eye disease by self-retained cryopreserved amniotic membrane. Ocul Surf. 2016;14(1):56–63. doi:10.1016/j.jtos.2015.07.003
  • McDonald MB, Sheha H, Tighe S, et al. Treatment outcomes in the dry eye amniotic membrane (DREAM) study. Clin Ophthalmol. 2018;12:677–681. doi:10.2147/OPTH.S162203
  • John T, Tighe S, Sheha H, et al. Corneal nerve regeneration after self-retained cryopreserved amniotic membrane in dry eye disease. J Ophthalmol. 2017;6404918:1–10. doi:10.1155/2017/6404918
  • Franz MG, Payne WG, Xing L, et al. The use of amnion-derived cellular cytokine solution to improve healing in acute and chronic wounds. Eplasty. 2008;8:188–199.
  • Steed DL, Trumpower C, Duffy D. Amnion-derived cellular cytokine solution. Eplasty. 2008;8:157–165.
  • Lemp MA. Report of the national eye institute/industry workshop on clinical trials in dry eyes. Clao. 1995;21(4):221–232.
  • Madrigal M, Rao KS, Riordan NH. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Trans Med. 2014;12:1–14. doi:10.1186/s12967-014-0260-8
  • Blau HM, Cosgrove BD, Ho ATV. The central role of muscle stem cells in regenerative failure with aging. Nat Med. 2015;21(8):854–862. doi:10.1038/nm.3918
  • Andersen RE, Lim DA. An ingredient for the elixir of youth. Cell Res. 2014;24(12):1381–1382. doi:10.1038/cr.2014.107
  • Schollhorn L, Bock F, Cursiefen C. Thrombospondin-1 as a regulator of corneal inflammation and lymphangiogenesis: effects on dry eye disease and graft immunology. J Ocul Pharmacol Ther. 2015;31(7):376–385. doi:10.1089/jop.2015.0020
  • Labus MB, Stirk CM, Thompson WD, Melvin WT. Expression of Wnt genes in early wound healing. Wound Repair Regen. 1998;6(1):58–64.
  • Bron AJ, De Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438–510. doi:10.1016/j.jtos.2017.05.011
  • Nebbioso M, Del Regno P, Gharbiya M, et al. Analysis of the pathogenic factors and management of dry eye in ocular surface disorders. Int J Mol Sci. 2017;18(8):pii: E1764. doi:10.3390/ijms18081764
  • Nebbioso M, Fameli V, Gharbiya M, et al. Investigational drugs in dry eye disease. Expert Opin Investig Drugs. 2016;25(12):1437–1446. doi:10.1080/13543784.2016.1249564
  • Murri MS, Moshirfar M, Birdsong OC, et al. Amniotic membrane extract and eye drops: a review of literature and clinical application. Clin Ophthalmol. 2018;12:1105–1112. doi:10.2147/OPTH.S165553
  • Xiao X, Luo P, Zhao H, et al. Amniotic membrane extract ameliorates benzalkonium chloride-induced dry eye in a murine model. Exp Eye Res. 2013;115:31–40. doi:10.1016/j.exer.2013.06.005

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.